OSE Immunotherapeutics Presents Clinical and Preclinical Data from its Immuno-Oncology Portfolio Read more about OSE Immunotherapeutics Presents Clinical and Preclinical Data from its Immuno-Oncology Portfolio
Panoro Energy - Acquisition of Minority Share in Panoro's Tunisian Business Read more about Panoro Energy - Acquisition of Minority Share in Panoro's Tunisian Business
Number of Shares and Voting Rights of Innate Pharma as of April 1, 2023 Read more about Number of Shares and Voting Rights of Innate Pharma as of April 1, 2023
BerGenBio Presents Data on STK11 Loss of Function and AXL Activation at AACR Read more about BerGenBio Presents Data on STK11 Loss of Function and AXL Activation at AACR
BioSenic receives key European patent from EPO, for further therapeutic development in cancer, infectious and immune diseases Read more about BioSenic receives key European patent from EPO, for further therapeutic development in cancer, infectious and immune diseases
Hyloris announces submission of Maxigesic® IV packaging data requested by the US FDA Read more about Hyloris announces submission of Maxigesic® IV packaging data requested by the US FDA
argenx Demonstrates Commitment to Redefining Treatment Goals for Generalized Myasthenia Gravis with Multiple Presentations at American Academy of Neurology 2023 Annual Meeting Read more about argenx Demonstrates Commitment to Redefining Treatment Goals for Generalized Myasthenia Gravis with Multiple Presentations at American Academy of Neurology 2023 Annual Meeting